MetaCap

Neogen Insider Trades

NASDAQ: NEOGHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

11.85+0.14 (+1.20%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $6.03K
Sales
0 · $0
Shares bought / sold
505 / 0
Net activity
Net buying $6,035

Neogen insider activity

Over the last 12 months, Neogen insiders reported 1 transaction on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $6,035 and sold $0 worth of stock, for net insider buying of $6,035. The most recent filing shows Nassif Mikheal (CEO) buying 505 shares at $11.95 on Oct 9, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NEOG's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

NEOG insider transactions

Neogen insider transactions
DateInsiderTypeSharesValueFiling
Oct 9, 2026Nassif MikhealCEOBuy505$6.03KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related